Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Director departure
CC transcript
Quarterly results
|
|
Aegerion Pharmaceuticals, Inc. (AEGR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2019 |
T-3/A
| Form T-3/A - Application for qualification of trust indentures: [Amend] |
| 07/19/2019 |
T-3
| Form T-3 - Application for qualification of trust indentures: |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 02/08/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/31/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/12/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/09/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 12/09/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 12/01/2016 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 12/01/2016 |
SC 13D/A
| Broadfin Capital, LLC reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| Plutzky Jorge MD (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| PERRY GREGORY D (See Remarks) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 200,000 options to buy
@ $19.58, valued at
$3.9M
Disposed/sold 40,000 options to buy
@ $19.52, valued at
$780.8k
Disposed/sold 200,000 options to buy
@ $5.71, valued at
$1.1M
Disposed/sold 69,000 options to buy
@ $2.46, valued at
$169.7k
Disposed/sold 35,000 restricted stock units
@ $0 |
|
| 11/30/2016 |
4
| Louis Roger (Chief Compliance Officer) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| Harshbarger Benjamin (General Counsel and Secretary) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| Chan Barbara Y (VP, Chief Accounting Officer) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| Buono Linda (Sr. VP, Human Resources) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 4,000 shares
@ $0
Disposed/sold 14,700 options to buy
@ $37.66, valued at
$553.6k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
| 11/30/2016 |
4
| THOMAS PAUL (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 36,978 shares
@ $0
Disposed/sold 23,521 options to buy
@ $15.26, valued at
$358.9k
Disposed/sold 12,854 options to buy
@ $15, valued at
$192.8k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
| 11/30/2016 |
4
| Szela Mary T (CEO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| Stern Donald K (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| SMITH SANDFORD D (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 2,890 shares
@ $0
Disposed/sold 16,435 options to buy
@ $16.28, valued at
$267.6k
Disposed/sold 8,569 options to buy
@ $15, valued at
$128.5k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
Disposed/sold 40,000 options to buy
@ $18.26, valued at
$730.4k
Disposed/sold 8,888 restricted stock units
@ $0 |
|
| 11/30/2016 |
4
| GOTTO ANTONIO M JR MD D PHIL (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 13,916 shares
@ $0
Disposed/sold 10,238 options to buy
@ $9.5, valued at
$97.3k
Disposed/sold 9,988 options to buy
@ $17.64, valued at
$176.2k
Disposed/sold 12,854 options to buy
@ $15, valued at
$192.8k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
| 11/30/2016 |
4
| Scheer David (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
4
| BARER SOL J (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 29,890 shares
@ $0
Disposed/sold 19,927 options to buy
@ $19.25, valued at
$383.6k
Disposed/sold 9,988 options to buy
@ $17.64, valued at
$176.2k
Disposed/sold 12,854 options to buy
@ $15, valued at
$192.8k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
| 11/30/2016 |
SC 13D/A
| Sarissa Capital Management LP reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 11/29/2016 |
8-K
| Quarterly results |
| 11/29/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/29/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
|
|
|